| Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance A Camgoz, EB Gencer, AU Ural, Y Baran Leukemia & lymphoma 54 (6), 1279-1287, 2013 | 64 | 2013 |
| RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug M Wermke, A Camgoz, M Paszkowski-Rogacz, S Thieme, M von Bonin, ... Blood, The Journal of the American Society of Hematology 125 (24), 3760-3768, 2015 | 63 | 2015 |
| Inactivation of cancer mutations utilizing CRISPR/Cas9 C Gebler, T Lohoff, M Paszkowski-Rogacz, J Mircetic, D Chakraborty, ... Journal of the National Cancer Institute 109 (1), djw183, 2017 | 47 | 2017 |
| A single reporter mouse line for Vika, Flp, Dre, and Cre-recombination M Karimova, O Baker, A Camgoz, R Naumann, F Buchholz, ... Scientific reports 8 (1), 14453, 2018 | 34 | 2018 |
| FOXR2 Stabilizes MYCN Protein and Identifies Non–MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome F Schmitt-Hoffner, S van Rijn, UH Toprak, M Mauermann, F Rosemann, ... Journal of Clinical Oncology 39 (29), 3217-3228, 2021 | 30 | 2021 |
| Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloidleukemia cells A Camgoz, EB Gencer, AU Ural, F Avcu, Y Baran Leukemia & lymphoma 52 (8), 1574-1584, 2011 | 27 | 2011 |
| EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma A Jenseit, A Camgöz, SM Pfister, M Kool Acta neuropathologica 143 (1), 1-13, 2022 | 26 | 2022 |
| Macromolecular Changes in Nilotinib Resistant K562 Cells; an In vitro Study by Fourier Transform Infrared Spectroscopy C Ceylan, A Camgoz, Y Baran Technology in cancer research & treatment 11 (4), 333-344, 2012 | 19 | 2012 |
| Comparative RNAi screens in isogenic human stem cells reveal SMARCA4 as a differential regulator C Güneş, M Paszkowski-Rogacz, S Rahmig, S Khattak, A Camgöz, ... Stem cell reports 12 (5), 1084-1098, 2019 | 11 | 2019 |
| STK3 is a therapeutic target for a subset of acute myeloid leukemias A Camgoz, M Paszkowski-Rogacz, S Satpathy, M Wermke, MV Hamann, ... Oncotarget 9 (39), 25458, 2018 | 11 | 2018 |
| CRISPR/Cas9 Screen in Gastric Cancer Patient‐Derived Organoids Reveals KDM1A‐NDRG1 Axis as a Targetable Vulnerability J Mircetic, A Camgöz, M Abohawya, L Ding, J Dietzel, SG Tobar, ... Small methods 7 (6), 2201605, 2023 | 9 | 2023 |
| RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations OA Sidorova, S Sayed, M Paszkowski-Rogacz, M Seifert, A Camgöz, ... Cells 11 (5), 854, 2022 | 5 | 2022 |
| 3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma K Okonechnikov, A Camgöz, O Chapman, S Wani, DE Park, JM Hübner, ... Nature Communications 14 (1), 2300, 2023 | 4 | 2023 |
| A genome wide shRNA screen in primary human AML cells identifies ROCK1 as a novel therapeutic target M Wermke, A Camgoz, M Paszkowski-Rogacz, S Thieme, M von Bonin, ... Blood 122 (21), 170, 2013 | 2 | 2013 |
| EPEN-07. USP7 IS AN INTERACTION PARTNER OF EZHIP AND POTENTIAL DRUGGABLE TARGET IN PFA EPENDYMOMAS A Jenseit, A Camgöz, M Mauermann, N Mack, B Schwalm, J Mohr, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| 3D genome conformation analysis in ST-EPN-ZFTA ependymoma identifies RCOR2 as a potential target A Camgoez, K Okonechnikov, O Chapman, M Maurmann, F Buchholz, ... Cancer Research 82 (12_Supplement), 3886-3886, 2022 | | 2022 |
| EPEN-18. Oncogenic 3D genome conformations identify novel therapeutic targets in ependymoma K Okonechnikov, A Camgöz, DE Park, O Chapman, JM Hübner, A Jenseit, ... Neuro-Oncology 24 (Supplement_1), i42-i42, 2022 | | 2022 |
| Abstract A25: Evaluation of Drug Disposition in Supratentorial Ependymoma J Benzel, M Sauter, N Mack, A Davis, J Weiss, P Uhl, J Burhenne, ... Cancer Research 80 (14_Supplement), A25-A25, 2020 | | 2020 |
| Evaluation of Drug Disposition in Supratentorial Ependymoma J Benzel, M Sauter, N Mack, A Davis, J Weiss, P Uhl, J Burhenne, ... CANCER RESEARCH 80 (14), 54-55, 2020 | | 2020 |
| RNAi Screen in Primary AML Cells to Identify New Therapeutic Targets A Camgöz Technische Universität Dresden, 2018 | | 2018 |
